Using claims-based measures to predict performance status score in patients with lung cancer
β Scribed by Ramzi G. Salloum; Thomas J. Smith; Gail A. Jensen; Jennifer Elston Lafata
- Publisher
- John Wiley and Sons
- Year
- 2010
- Tongue
- English
- Weight
- 160 KB
- Volume
- 117
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## FOR THE UCLA SOLID TUMOR STUDY GROUP11 Serial assessments of Karnofsky performance status (KPS) and of the Functional Living Index-Cancer (FLIC) have been used to estimate the quality of life (QOL) of patients in a prospective, randomized trial of supportive care versus supportive care given wi
## Abstract The importance of epidermal growth factor receptor (EGFR) gene mutation has been recognized in nonsmall cell lung cancer (NSCLC), requiring the standardization of mutation screening system including the kind of samples. Here, we examined the __EGFR__ mutation status in 61 pleural fluid